Wednesday, July 8, 2026
🇺🇸 FDA

pharma · COVID-19 · Poliomyelitis

Sinovac Research and

Sinovac Research and Development Co.,

Sinovac Research and clinical programs — 47 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Dhaka, CN HQ
2022 Founded
9 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Dhaka, CN
Founded
2022
Employees
9
Programs
115
Drugs
54
Patents
0
Official website ↗ All projects Drug pipeline News & analysis
Intelligence · Clinical Programs

Sinovac Research and projects

47 ClinicalTrials.gov programs sponsored by Sinovac Research and.

Sinovac Research and has 47 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

47 programs

Clinical programs

  1. 2 doses of HAV

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  2. 2012-2013 trivalent seasonal influenza vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  3. 2wIPV+1sIPV

    Sinovac Research and Development Co.,

    Poliomyelitis

    approved mab active

    1 trial

  4. 5000 volunteers (6-35 months)-EV71 vaccine

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  5. Adult group in immunogenicity and safety study of combined immunization

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  6. COVID-19 Vaccine (Vero cell), Inactivated

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  7. Concomitant administration of EV71 vaccine with EPI vaccines

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  8. Concomitant administration of EV71vaccine with EPI vaccines

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  9. EV71 Vaccine

    Sinovac Research and Development Co.,

    EV71 Vaccine

    approved mab completed

    1 trial

  10. EV71 inactived vaccine（Vero cells）

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  11. EV71 vaccine

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  12. Experimental 23-valent PPV

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    approved mab completed

    1 trial

  13. Experimental 23-valent Pneumococcal

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    approved mab completed

    1 trial

  14. Experimental Group

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    4 trials

  15. Experimental Vaccine

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab active

    1 trial

  16. Experimental vaccine 1

    Sinovac Research and Development Co.,

    COVID-19

    approved mab on hold

    1 trial

  17. H1N1 influenza A Vaccine (PANFLU.1)

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  18. Healive+Healive

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  19. Healive® Lot 1

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  20. High-dosage SARS-CoV-2 vaccine

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    1 trial

  21. Inactivated HAV vaccine

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  22. Inactivated Hepatitis A vaccine (HAV)

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  23. Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    1 trial

  24. Inactivated SARS-CoV-2 Vaccine (Vero cell）

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  25. Investigational 23-valent PPV

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    approved mab completed

    2 trials

  26. Investigational live attenuated varicella vaccine

    Sinovac Research and Development Co.,

    Varicella

    approved mab active

    4 trials

  27. Live attenuated varicella vaccine

    Sinovac Research and Development Co.,

    Varicella

    approved mab active

    3 trials

  28. Mumps vaccine

    Sinovac Research and Development Co.,

    Mumps

    approved mab completed

    1 trial

  29. Mumps vaccine, Live (MV)

    Sinovac Research and Development Co.,

    Mumps

    approved mab active

    1 trial

  30. PRO-HAV-MA4001-LN

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab active

    1 trial

  31. PRO-INF4-MA4002-JStz

    Sinovac Research and Development Co.,

    Influenza and Pneumonia

    approved mab completed

    1 trial

  32. PRO-PanFlu-4001

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  33. PRO-PanFlu-4001-1

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  34. PRO-QINF-4001

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  35. PRO-QINF-4003

    Sinovac Research and Development Co.,

    Seasonal Influenza

    approved mab completed

    1 trial

  36. PRO-nCOV-4010

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  37. Pandemic influenza A/H1N1 vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  38. SARS-CoV-2 Inactivated Vaccine

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    2 trials

  39. The live attenuated varicella vaccine and the inactivated hepatitis A vaccine

    Sinovac Research and Development Co.,

    Varicella

    approved mab completed

    1 trial

  40. Two doses of quadrivalent influenza vaccine

    Sinovac Research and Development Co.,

    Seasonal Influenza

    approved mab completed

    1 trial

  41. Vaicella Vaccine+DTaP on Day 0, MMR on Day 30

    Sinovac Research and Development Co.,

    Varicella (chickenpox)

    approved mab active

    1 trial

  42. Varicella vaccine

    Sinovac Research and Development Co.,

    VZV

    approved mab completed

    1 trial

  43. Varicella vaccine+TIV

    Sinovac Research and Development Co.,

    Varicella

    approved mab completed

    1 trial

  44. sIPV

    Sinovac Research and Development Co.,

    Poliomyelitis

    approved mab active

    3 trials

  45. sIPV vaccine /DTaP vaccine

    Sinovac Research and Development Co.,

    Poliomyelitis

    approved mab completed

    1 trial

  46. seasonal split influenza vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  47. trivalent seasonal influenza vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

Frequently asked questions

How many clinical projects does Sinovac Research and have?

47 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.